Skip to content
2000
Volume 2, Issue 1
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

Floating tablets extend drug residence time, enhance bioavailability and promote the delivery of local drugs to the stomach. With this objective, floating tablets were prepared for the treatment of gastric ulcers containing aqueous extract of liquorice and Isabgol.

Tablets containing HPMC K100M (hydrophilic polymer), liquorice extract, sodium bicarbonate (gas generating agent), talc, and magnesium stearate were prepared using direct compression method. Physical parameters of formulations such as diameter, thickness, hardness, friability, weight uniformity, drug content, buoyancy time, dissolution, and the mechanism for drug release, were assessed. The formulations have been optimized based on buoyancy time and in- vitro drug release.

The diameter of all formulations was in the range 11.310-11.833 mm; thickness was in the range 4.02-4.071 mm. The hardness ranged from 3.1 to 3.4 kg/cm. All the formulations passed the USP requirements for friability and uniformity of weight. All tablet formulations had a buoyancy period of less than 5 min and throughout the research, the tablet stayed in floating condition. All tablet formulations were accompanied in drug discharge by zero-order kinetics and Korsmeyer-Peppas model.

It was discovered that the optimized formulation was F7, which released 98.5 percent of the drug in 8 hr. , while the buoyancy time was 3.5 min. For gastroretentive drug delivery systems, formulations containing Isabgol, sodium bicarbonate and HPMC K100 M in combination may be promising.

Loading

Article metrics loading...

/content/journals/cnt/10.2174/2665978601999200930143521
2021-03-01
2024-12-25
Loading full text...

Full text loading...

References

  1. UpendraN. AshokK.P. Charu BhartiC. Gulati, N. Formulation and evaluation of nutraceutical tablet using herbal drugs by direct compression method.J. Drug Deliv. Ther.2014424751
    [Google Scholar]
  2. ShanthiA. RadhaR. JaysreeN. Antiulcer activity of newly formulated herbal capsule.Asian J. Pharm. Clin. Res.20114386
    [Google Scholar]
  3. WaughA. GrantA. Wilson, R.; Anatomy & Physiology in Health and Illness.11th edNew YorkChurchill Livingstone2013315
    [Google Scholar]
  4. YeoleP.G. floating drug delivery system: Need and development Ind.J. Pharm. Sci.2005673265272
    [Google Scholar]
  5. GargR. GuptaG.D. Progress in controlled gastrointestinal delivery systems.Trop. J. Pharm. Res.200871055106610.4314/tjpr.v7i3.14691
    [Google Scholar]
  6. SinghB.N. KimK.H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.J. Control. Release200063323525910.1016/S0168‑3659(99)00204‑7PMID:10601721
    [Google Scholar]
  7. RubinsteinA. FriendD.R. Specific delivery to the gastrointestinal tract.Domb, A. J. Chichester; Pharmacotherapy, P.S-S., Ed.; Wiley, 1994, pp. 283-285.
    [Google Scholar]
  8. StreubelA. SiepmannJ. BodmeierR. Drug delivery to the upper small intestine window using gastroretentive technologies.Curr. Opin. Pharmacol.20066550150810.1016/j.coph.2006.04.007PMID:16890020
    [Google Scholar]
  9. DeshpandeA.A. ShahN.H. RhodesC.T. MalickW. Development of a novel controlled-release system for gastric retention.Pharm. Res.199714681581910.1023/A:1012171010492PMID:9210203
    [Google Scholar]
  10. GohelM.C. PatelM.M. AminA.F. Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation.Drug Dev. Ind. Pharm.200329556557410.1081/DDC‑120018645PMID:12779286
    [Google Scholar]
  11. BennettA. MelhuishP.B. StamfordI.F. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo.Br. J. Pharmacol.198586369369510.1111/j.1476‑5381.1985.tb08947.xPMID:3840708
    [Google Scholar]
  12. YanoS. HaradaM. WatanabeK. NakamaruK. HatakeyamaY. ShibataS. TakahashiK. MoriT. HirabayashiK. TakedaM. Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models.Chem. Pharm. Bull. (Tokyo)19893792500250410.1248/cpb.37.2500PMID:2605700
    [Google Scholar]
  13. AlyA.M. Al-AlousiL. SalemH.A. Licorice: A possible anti-inflammatory and anti-ulcer drug.AAPS PharmSciTech200561E74E8210.1208/pt060113PMID:16353966
    [Google Scholar]
  14. MasoomehM.J. KiarashG. In vitro susceptibility of Helicobacter pylori to licorice extract.Iran. J. Pharm. Res.200766972
    [Google Scholar]
  15. TiwariR.K. SinghL. SharmaV. SinghP. Formulation development of fast dissolving tablet of clove - The best nutraceutical analgesic tablet. Asia.F. Sci.20181317
    [Google Scholar]
  16. TiwariR.K. SinghL. SharmaV. Performance optimization of sustained release arginine alginate microbeads with a natural polysaccharide.J. Pharma. Res. Int.201717511110.9734/JPRI/2017/34305
    [Google Scholar]
  17. SinghL. NandaA. SharmaS. SharmaV. Design optimization and evaluation of gastric floating matrix tablet of glipizide.Trop. J. Pharm. Res.201312686987610.4314/tjpr.v12i6.2
    [Google Scholar]
  18. SharmaV. SinghL. Formulation variable study and optimization of taste masked mouth dissolving tablets using design of experiment.D. Dev. Thera.201561202810.4103/2394‑2002.148887
    [Google Scholar]
  19. SinghL. NandaA. SharmaS. SharmaV. Formulation by design: understanding the formulation variables and optimisation of glipizide buoyant bioadhesive microcarriers by central composite design.Malays. J. Pharm. Sci.2014121118
    [Google Scholar]
  20. BasakS.C. RaoK.N. ManavalanR. RaoP.R. Development and in vitro evaluation of an oral floating matrix tablet formulation of ciprofloxacin.Indian J. Pharm. Sci.200466313316
    [Google Scholar]
  21. NandaA. SinghL. SharmaS. SharmaV. Performance optimization of buoyant beads of anti-diabetic drug using quality by design (QbD).Lat. Am. J. Pharm.20143311423
    [Google Scholar]
  22. SharmaD. Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders.ISRN Pharmaceutics,20138Article ID 674507
    [Google Scholar]
  23. RitgerP.L. PeppasN.A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices.J. Control. Release19875374210.1016/0168‑3659(87)90035‑6
    [Google Scholar]
  24. ThadkalaK. Perma KumariN.P. PrathyushaR. RajuA. Formulation development, optimization and characterization of floating beads of captopril. Int. J. Pharm. Res. Allied.Sci.201323246
    [Google Scholar]
/content/journals/cnt/10.2174/2665978601999200930143521
Loading
/content/journals/cnt/10.2174/2665978601999200930143521
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test